GlassScriptPhysician profile
Grayson P Connors
NPI 1629496401
$47,478.04
in general payments reported to CMS, 2019-2025
14 companies · $8,858 in 2025
The $8,858 reported for 2025 was more than what 86% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,500 · 2020: $4,525 · 2021: $1,163 · 2022: $2,082 · 2023: $5,561 · 2024: $21K · 2025: $8,858.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $31K · Travel and Lodging: $2,303 · Food and Beverage: $2,206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $30,699.27 |
| Travel and Lodging | $2,302.65 |
| Food and Beverage | $2,206.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $31,240.03 | 2021-2025 | Tfn-Advance, Velys |
| Smith+Nephew, INC. | $9,032.63 | 2019-2024 | Redapt |
| Depuy Synthes Sales INC. | $2,908.57 | 2021-2025 | Velys, Attune, Emphasys |
| Depuy Synthes Products, INC. | $2,742.41 | 2022-2025 | Velys, Kincise |
| Stryker Corporation | $450.27 | 2021-2025 | Gamma |
| Zimmer Biomet Holdings, INC. | $394.55 | 2022-2024 | Persona, Mymobility Platform |
| Pacira Pharmaceuticals Incorporated | $189.61 | 2021-2025 | Iovera, Zilretta, Exparel |
| Vericel Corporation | $127.00 | 2023 | Maci |
| Bioventus LLC | $115.19 | 2023-2024 | Durolane, Durolane |
| Pacira Therapeutics, INC. | $114.91 | 2021 | |
| Ferring Pharmaceuticals INC. | $67.04 | 2023-2025 | Euflexxa |
| Exactech, INC. | $42.94 | 2022 | |
| Baudax Bio INC. | $27.53 | 2022 | |
| Microport Orthopedics INC | $25.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grayson Connors listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.